Sublingual Immunotherapy Stops Onset and Worsening of Asthma
The French EfficAPSI study confirmed that sublingual liquid immunotherapy or "desensitization" reduces the risks for asthma onset and the worsening of asthma in patients with allergic rhinitis.
France General Pascal Demoly Stallergenes Greer Philippe Devillier French Health Authority Montpellier University Hospital
Source: medscape.com